Find our Science Published in

"A passionate and deeply knowledgeable team seeking to create meaningful societal impact by harnessing the power of exponential technologies."

Current
Press

Ilissa Larimore Appointed Chief Commercial Officer at Solarea Bio

June 26, 2024

Solarea announces the appointment of Ilissa Larimore as Chief Commercial Officer (CCO). Ilissa joins Solarea Bio with over 20 years of experience in consumer health, personalized wellness and practitioner engagement to help individuals achieve optimal health.

Solarea Bio Announces the Beta Launch of Bondia™, a Novel Daily Medical Food Helping Menopausal Women Manage Bone Loss

May 8, 2024

The complete beta launch experience, known as the Beta Complete Journey, includes a baseline total body DEXA scan, a year of Bondia™ capsules, and access to an accompanying mobile app.

The NIH/National Institute on Aging has awarded a R01 $3 million grant to study the impact of a medical food developed by Solarea Bio

August 25, 2023

Hebrew SeniorLife, United States Department of Agriculture (USDA) Human Nutrition Research Center on Aging (HNRCA) at Tufts University, Maine Medical Center Research Institute, and Solarea Bio are grant recipients.

Solarea Bio Announces First Close of Series B Financing Round

May 8, 2023

Solarea Bio announced today a first closing of $15m in a Series B financing led by S2G Ventures with continued participation of Bold Capital Partners, Viking Global Investors, and GG 1978 SICAF SIF.

Recent
Company
News